Ligand validation:7DIS

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

MPD is a Ligand Of Interest in 7DIS designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7DIS_MPD_A_202	44%	92%	0.165	0.893	0.27	0.28	-	-	2	0	100%	1
4MZC_MPD_A_202	50%	86%	0.151	0.9	0.28	0.44	-	-	5	0	100%	0.65
7DIM_MPD_A_202	47%	92%	0.152	0.892	0.33	0.21	-	-	10	0	100%	1
7DIP_MPD_A_202	47%	93%	0.155	0.893	0.24	0.24	-	-	0	0	100%	1
7DIU_MPD_A_202	44%	92%	0.186	0.913	0.24	0.3	-	-	0	0	100%	1
7DIO_MPD_A_202	43%	92%	0.173	0.895	0.23	0.31	-	-	0	0	100%	1
9D77_MPD_A_505	100%	87%	0.032	0.998	0.16	0.52	-	-	1	0	100%	1
9H8Q_MPD_B_602	100%	82%	0.039	0.988	0.35	0.44	-	-	3	0	100%	1
9MMI_MPD_B_301	100%	79%	0.04	0.983	0.3	0.56	-	-	4	0	100%	1
7Z6B_MPD_B_307	99%	74%	0.057	0.986	0.42	0.59	-	-	0	0	100%	1
7ZOB_MPD_F_202	99%	72%	0.056	0.983	0.44	0.65	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.